BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25131878)

  • 1. [A patient with paclitaxel hypersensitivity treated with nab-paclitaxel].
    Ouchi A; Ouchi A; Asano M; Aono K; Watanabe T; Kato T
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):889-91. PubMed ID: 25131878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outcome and Problems of Nab-Paclitaxel Therapy for Gastric Cancer in Clinical Practice].
    Doi T; Ishikawa T; Okayama T; Dohi O; Yoshida N; Kamada K; Katada K; Sogame Y; Uchiyama K; Handa O; Takagi T; Yasuda H; Sakagami J; Konishi H; Naito Y; Itoh Y
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):211-4. PubMed ID: 27067684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safe treatment of lung squamous cell carcinoma with nanoparticle albumin-bound Paclitaxel in a patient with a previous hypersensitivity reaction after docetaxel administration].
    Uenami T; Mori M; Ageshio F; Kagawa H; Matsui H; Satomi A; Niinaka M; Kimura H; Yano Y; Yoneda T; Yamaguchi T; Yokota S
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):375-7. PubMed ID: 25812512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of liver metastases from gastric cancer successfully treated with weekly paclitaxel chemotherapy].
    Okada K; Ebisui C; Murakami M; Yanagisawa T; Okamura S; Murata K; Yokouchi H; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2348-50. PubMed ID: 23268073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose dexamethasone paclitaxel premedication.
    Micha JP; Rettenmaier MA; Dillman R; Fraser P; Birk C; Brown JV
    Gynecol Oncol; 1998 May; 69(2):122-4. PubMed ID: 9600818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of short-time premedication with d-chlorpheniramine maleate injection for paclitaxel-induced hypersensitivity reaction].
    Harada T; Doi M; Yamada Y; Akase T
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1347-51. PubMed ID: 18701846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience of nab-Paclitaxel treatment in 31 patients with breast cancer].
    Tauchi Y; Kashiwagi S; Ishihara S; Asano Y; Sakimura C; Kurata K; Tokumoto M; Morisaki T; Noda S; Kawajiri H; Takashima T; Onoda N; Hirakawa K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1948-50. PubMed ID: 25731385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Taxane-Pretreated Metastatic Gastric Cancer with Excellent Response to Nab-Paclitaxel].
    Kawabata R; Kimura Y; Kawase T; Yoshikawa M; Kameda C; Matsumura T; Koga C; Murakami M; Hirota M; Noura S; Ikenaga M; Shimizu J; Hasegawa J
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2088-90. PubMed ID: 26805273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Weekly paclitaxel therapy leading to complete disappearance of multiple liver metastases and subsequent surgical resection for advanced gastric cancer].
    Jin Y; Hasuo K; Tsuchida K; Sawazaki S; Hayashi S; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):647-9. PubMed ID: 21498997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration.
    Braverman AS; Rao S; Salvatti ME; Adamson B; McManus M; Pierre S
    Chemotherapy; 2005 May; 51(2-3):116-9. PubMed ID: 15886470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced gastric cancer with multiple liver metastases completely responding long term to paclitaxel plus S-1 therapy].
    Kanou M; Kurisu Y; Akagi S; Tanaka T; Toge K
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):143-5. PubMed ID: 20087050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful Weekly Nanoparticle Albumin-Bound Paclitaxel Therapy for a Case of Gastric Cancer with Oncological Emergency of Liver Metastasis].
    Setoguchi T; Akai T; Sunayama K; Ori T
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):361-3. PubMed ID: 27067856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complete Remission after Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Non-Small-Cell Lung Cancer].
    Sugiura Y; Hashizume T; Kawai O; Ohkubo Y; Fusegawa H; Araki N; Kaseda S; Nemoto E
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1095-7. PubMed ID: 26469167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of effective weekly paclitaxel administration for advanced gastric cancer associated with diabetes mellitus -about the control of blood glucose when dexamethasone for prophylaxis against paclitaxel-associated hypersensitivity reactions to the diabetic has been administered].
    Yoshizawa Y; Goto T; Matsubara T; Maezawa K; Mizukami H; Saito M; Nemoto H; Sasaya S; Sanada Y
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):641-4. PubMed ID: 18408435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy.
    Kanazawa Y; Fujita I; Kakinuma D; Arai H; Matsuno K; Shimoda T; Ko K; Kato S; Uchida E
    Anticancer Res; 2017 May; 37(5):2715-2720. PubMed ID: 28476850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
    Takashima A; Shitara K; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Kimura Y; Amagai K; Fujii H; Muro K; Esaki T; Choda Y; Takano T; Chin K; Sato A; Goto M; Fukushima N; Hara T; Machida N; Ohta M; Boku N; Shimura M; Morita S; Koizumi W
    Gastric Cancer; 2019 Jan; 22(1):155-163. PubMed ID: 29855738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination.
    Matano D; Moriwaki T; Tange Y; Niisato Y; Yamaura M; Nagase M; Suganuma D; Takagi Taketa K; Iwai K; Enami C; Yamamoto Y; Hyodo I
    Intern Med; 2017; 56(8):921-923. PubMed ID: 28420840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel and nab-paclitaxel are safe alternative options for patients with gynecologic malignancies following hypersensitivity reaction to paclitaxel.
    Brightwell R; Handel E ; Eng K; Grzankowski K; Frederick P; Odunsi K; Lele S
    Eur J Gynaecol Oncol; 2016; 37(6):800-802. PubMed ID: 29943924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.
    Bookman MA; Kloth DD; Kover PE; Smolinski S; Ozols RF
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-13-S19-15. PubMed ID: 9427258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.